Stock 688799 HUNAN WARRANT PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Warrant Pharmaceutical Co.,Ltd

Equities

688799

CNE100004P73

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
43.8 CNY -0.93% Intraday chart for Hunan Warrant Pharmaceutical Co.,Ltd -5.28% -10.50%
Apr. 19 Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 25 Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials, chemical pharmaceutical preparations and traditional Chinese medicine preparations. The Company's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The Company mainly conducts business within the domestic market.

Number of employees: 1,162

Sales per Business

CNY in Million2022Weight2023Weight Delta
Preparation
77.7 %
1,061 82.1 % 1,114 77.7 % +4.93%
APIs and Intermediates
20.0 %
207 16.0 % 287 20.0 % +39.04%
Other Business
2.0 %
19 1.5 % 29 2.0 % +52.75%
Plant Extracts and Foods
0.2 %
6 0.4 % 3 0.2 % -53.02%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.8 %
1,264 99.2 % 1,387 98.8 % +9.73%
Overseas
1.2 %
10 0.8 % 17 1.2 % +72.28%

Managers

Managers TitleAgeSince
Ben Dong Huang CEO
 Chief Executive Officer 60 11-02-28
Xiang Qi Cao DFI
 Director of Finance/CFO 50 21-10-31
Xiang Gao BRD
 Director/Board Member 53 02-09-30
Meng Chun Li BRD
 Director/Board Member 55 15-10-31
Qiao Qiao IRC
 Investor Relations Contact 50 -
Lin Dou SEC
 Corporate Secretary 48 12-09-30

Members of the board

Members of the board TitleAgeSince
Fei Ma BRD
 Director/Board Member 53 21-10-25
Peng Zhang BRD
 Director/Board Member 48 22-04-17
Cai Lian Kang BRD
 Director/Board Member 50 21-10-25
Ben Dong Huang CEO
 Chief Executive Officer 60 11-02-28
Yan Xu BRD
 Director/Board Member 59 03-03-31
Meng Chun Li BRD
 Director/Board Member 55 15-10-31
Xiang Gao BRD
 Director/Board Member 53 02-09-30
Yan Jin CHM
 Chairman 61 15-10-31
Chun Wu BRD
 Director/Board Member 54 21-10-25
Jun Xie BRD
 Director/Board Member 60 21-10-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 93,800,000 29,666,889 ( 31.63 %) 0 31.63 %

Shareholders

NameEquities%Valuation
Essence Fund Co., Ltd.
4.062 %
811,347 4.062 % 5 M ¥
Penghua Fund Management Co., Ltd.
1.917 %
382,884 1.917 % 2 M ¥
China Southern Asset Management Co., Ltd.
1.516 %
302,870 1.516 % 2 M ¥
Hwabao WP Fund Management Co., Ltd.
0.8479 %
169,368 0.8479 % 1 M ¥
Nuode Asset Management Co., Ltd.
0.6968 %
139,192 0.6968 % 864 964 ¥
GF Fund Management Co., Ltd.
0.5449 %
108,843 0.5449 % 676 370 ¥
Western Leadbank Fund Management Co., Ltd
0.5257 %
105,004 0.5257 % 652 514 ¥
China Asset Management Co., Ltd.
0.4823 %
96,343 0.4823 % 598 693 ¥
Broad Fund Management Co. Ltd.
0.4165 %
83,194 0.4165 % 516 982 ¥
Minsheng Royal Fund Management Co., Ltd.
0.3497 %
69,845 0.3497 % 434 029 ¥

Company contact information

Hunan Warrant Pharmaceutical Co., Ltd.

Minmetals Lugu Science & Tech Park Building C6-C7, 28 Lutian Road

410006, Changsha

+

http://www.warrant.com.cn
address Hunan Warrant Pharmaceutical Co.,Ltd(688799)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
43.8 CNY
Average target price
59 CNY
Spread / Average Target
+34.70%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN WARRANT PHARMACEUTICAL CO.,LTD Stock Hunan Warrant Pharmaceutical Co.,Ltd
-10.50% 574M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.77% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 334B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.77% 239B
NOVARTIS AG Stock Novartis AG
+9.13% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.97% 203B
AMGEN INC. Stock Amgen Inc.
+9.27% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688799 Stock
  4. Company Hunan Warrant Pharmaceutical Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW